Investing Profile

Maximilian Winter(413)

VC

Harmonizing Human Health

Photo of Maximilian Winter, General Partner at Harmonix Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Picture
Picture
Picture

14 Investors

Connected to Ian Rountree (Cantos Ventures), Josh Kopelman (First Round Capital), Aydin Senkut (Felicis Ventures), and 11 other investors on Signal.

University of Arizona Network
11 CONNECTIONS
cb
Harmonix Fund General Partner
$250K - $3.0M
$1M
51
CompanyStageDateRound SizeTotal Raised
Attivare Therapeutics
Series Seed 1 PreferredAug 2021$5M
$11M
Co-investors: Peter Bordes (Trajectory Ventures), Eric Anschutz
Caresyntax
Series C - 2 PreferredJul 2021$100M
$100M
Co-investors: Alireza Masrour (Plug & Play Ventures)
Strateos
Series BJun 2021$56M
Series AFeb 2015$8.5M
$97M
Co-investors: Josh Wolfe (Lux Capital Management), Adam Goulburn (Lux Capital Management), Matt Ocko (DCVC (Data Collective)), Brad Gillespie (IA Ventures), Paul Buchheit (Y Combinator), Armen Vidian
Loft Orbital Solutions Inc.
Convertible Promissory NoteJun 2021$17M
$17M
Co-investors: Ashley Flucas (Flucas Ventures)
Sorcero
Series A-1 PreferredJun 2021$5.7M
$5.7M
Co-investors: Oliver Libby (H/L Ventures), william schneiderman
Scribe Biosciences
Convertible Promissory NoteMay 2021$4.5M
$4.5M
XCures
Series A PreferredMay 2021$13M
SeedSep 2020
$13M
Atlas Space
Convertible Promissory NoteApr 2021$5M
Post Series A BridgeApr 2020
$5M
Investing at the intersection of life sciences, healthcare, and deep tech. Many investments are platforms and tend to be computational bio-platforms.
Sectors outside of health, bio, and deep tech.
General Partner Harmonix Fund2017 - Present
University of Arizona Bachelor of Science Business/Finance